Jiangsu Nhwa Pharmaceutical Co., Ltd.
002262
株式のランク
#4736
Jiangsu Nhwa Pharmaceutical Co., LTD operates as a global pharmaceutical... Jiangsu Nhwa Pharmaceutical Co., LTD operates as a global pharmaceutical entity, focusing on the research, production, and sale of treatments for the central nervous system, along with cardiovascular and cerebrovascular ailments. Its comprehensive product line includes therapeutics for anesthesia, psychiatry, and neurological disorders. Additionally, the company is a supplier of Active Pharmaceutical Ingredients (APIs), specifically for central nervous system, anesthetic, and sedative applications, among others. The firm was established in 1978 and is based in Xuzhou, China.
株価
$3.19
時価総額
$3.23B
変化（1日）
1.20%
変化（1年）
-12.98%
国
CN
取引 Jiangsu Nhwa Pharmaceutical Co., Ltd. (002262)
カテゴリー
Healthcare
Jiangsu Nhwa Pharmaceutical Co., Ltd.（002262）の配当利回りの履歴
Jiangsu Nhwa Pharmaceutical Co., Ltd.（銘柄コード: 002262）の配当利回り（TTM）は2023-12-31時点で0.73%です。
過去5年間の平均配当利回り: 0.82%
過去5年間の平均配当利回り: 0.82%
Jiangsu Nhwa Pharmaceutical Co., Ltd.（002262）の2005から2026までの配当利回りの履歴
各年末時点の配当利回り（TTM）
| 年 | 配当利回り | 変化 |
|---|---|---|
| 2026 (TTM) | 1.89% | 44.27% |
| 2024 | 1.31% | 79.45% |
| 2023 | 0.73% | -9.88% |
| 2022 | 0.81% | 26.56% |
| 2021 | 0.64% | 1.59% |
| 2020 | 0.63% | -4.55% |
| 2019 | 0.66% | -9.59% |
| 2018 | 0.73% | 121.21% |
| 2017 | 0.33% | 6.45% |
| 2016 | 0.31% | 6.90% |
| 2015 | 0.29% | -23.68% |
| 2014 | 0.38% | -2.56% |
| 2013 | 0.39% | -22.00% |
| 2012 | 0.50% | -29.58% |
| 2011 | 0.71% | 69.05% |
| 2010 | 0.42% | -53.85% |
| 2009 | 0.91% | -22.88% |
| 2008 | 1.18% | 93.44% |
| 2007 | 0.61% | -72.40% |
| 2006 | 2.21% | 190.79% |
| 2005 | 0.76% | 0.00% |
類似企業または競合他社の配当利回り（TTM）
| 企業 | 配当利回り | 国 |
|---|---|---|
| 0.00% |
DE
|
|
| 0.00% |
DE
|
|
| 0.00% |
JP
|
|
| 0.00% |
CH
|
|
| 0.91% |
IN
|
